Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice

Conclusion In this prospective study over a four-month period in clinical practice, ivabradine effectively reduced HR, angina attacks, and nitrate consumption in patients with AP with or without concomitant BB therapy. Ivabradine improved CCS scores and achieved a high treatment response rate with good general tolerability. Funding Servier. Trial registration Controlled-trials.com identifier, ISRCTN73861224.

http://link.springer.com/10.1007/s12325-016-0377-7

Source: Advances in Therapy - July 17, 2016 Category: Drugs & Pharmacology Source Type: research